D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Broadcom
AVGO
|
+$596M |
| 2 |
Accenture
ACN
|
+$470M |
| 3 |
Intel
INTC
|
+$412M |
| 4 |
Adobe
ADBE
|
+$365M |
| 5 |
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
|
+$258M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$1.5B |
| 2 |
Apple
AAPL
|
+$1.02B |
| 3 |
Microsoft
MSFT
|
+$776M |
| 4 |
Netflix
NFLX
|
+$688M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| 1 | Technology | 26.84% |
| 2 | Consumer Discretionary | 15.19% |
| 3 | Financials | 10.39% |
| 4 | Healthcare | 9.6% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Chemours
CC
$2.44B
| $6.52M | 0.01% |
288,767
+256,737
| +802% | +$5.79M |
|
1027
American Vanguard Corp
AVD
$152M
| $6.5M | 0.01% |
755,728
+64,765
| +9% | +$557K |
|
1028
Scotiabank
BNS
$79.4B
| $6.49M | 0.01% |
141,946
-174,359
| -55% | -$7.98M |
|
1029
Constellium
CSTM
$2.09B
| $6.48M | 0.01% |
343,973
+311,607
| +963% | +$5.87M |
|
1030
Air Products & Chemicals
APD
$65.5B
| $6.46M | 0.01% |
25,035
-321,195
| -93% | -$82.9M |
|
1031
Bumble
BMBL
$702M
| $6.45M | 0.01% |
613,322
-198,707
| -24% | -$2.09M |
|
1032
NerdWallet
NRDS
$788M
| $6.44M | 0.01% |
440,953
+213,498
| +94% | +$3.12M |
|
1033
Theravance Biopharma
TBPH
$690M
| $6.43M | 0.01% |
758,080
-23,505
| -3% | -$199K |
|
1034
First Interstate BancSystem
FIBK
$3.37B
| $6.43M | 0.01% |
231,467
+108,415
| +88% | +$3.01M |
|
1035
Booz Allen Hamilton
BAH
$12.6B
| $6.41M | 0.01% |
41,664
-35,289
| -46% | -$5.43M |
|
1036
Monro
MNRO
$507M
| $6.41M | 0.01% |
268,554
+162,454
| +153% | +$3.88M |
|
1037
Perrigo
PRGO
$3.04B
| $6.41M | 0.01% |
+249,424
| New | +$6.41M |
|
1038
Collegium Pharmaceutical
COLL
$1.19B
| $6.4M | 0.01% |
198,863
-286
| -0.1% | -$9.21K |
|
1039
Omeros
OMER
$286M
| $6.4M | 0.01% |
1,576,383
-101,300
| -6% | -$411K |
|
1040
Belden
BDC
$5.15B
| $6.4M | 0.01% |
68,223
+24,314
| +55% | +$2.28M |
|
1041
Stanley Black & Decker
SWK
$11.9B
| $6.39M | 0.01% |
80,015
+6,073
| +8% | +$485K |
|
1042
HF Sinclair
DINO
$9.57B
| $6.38M | 0.01% |
119,582
+11,766
| +11% | +$628K |
|
1043
Enovis
ENOV
$1.81B
| $6.37M | 0.01% |
140,841
-14,343
| -9% | -$648K |
|
1044
Guess, Inc.
GES
$868M
| $6.36M | 0.01% |
311,526
-169,559
| -35% | -$3.46M |
|
1045
monday.com
MNDY
$9.89B
| $6.34M | 0.01% |
26,340
-118,368
| -82% | -$28.5M |
|
1046
AdvanSix
ASIX
$554M
| $6.34M | 0.01% |
276,522
+55,166
| +25% | +$1.26M |
|
1047
CVB Financial
CVBF
$2.8B
| $6.33M | 0.01% |
367,451
+171,119
| +87% | +$2.95M |
|
1048
Imperial Oil
IMO
$46.8B
| $6.32M | 0.01% |
92,701
+39,641
| +75% | +$2.7M |
|
|
TIGR
1049
UP Fintech Holding
TIGR
$2B
| $6.32M | 0.01% |
1,504,140
+611,095
| +68% | +$2.57M |
|
1050
Xenon Pharmaceuticals
XENE
$2.86B
| $6.31M | 0.01% |
161,722
-36,804
| -19% | -$1.43M |
|